{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":337,"total_is_capped":false,"direct_labels_cover":3,"predictions_cover":337,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"108a9af0a2b0","filters":{"venue":"Clinical Therapeutics"}},"results":[{"id":"W2562743482","doi":"10.1016/j.clinthera.2016.11.002","title":"SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis","year":2016,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":344,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; University of Toronto; Winnipeg Regional Health Authority; Health Sciences Centre; University of Manitoba; LMC Diabetes & Endocrinology (Canada)","funders":"Yale University; AstraZeneca","keywords":"Medicine; Diabetic ketoacidosis; Diabetes mellitus; Glycemic; Intensive care medicine; Insulin; Ketoacidosis; Type 2 diabetes; Internal medicine; Type 1 diabetes; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1281971846520836,"gpt":0.4582817856458242,"spread":0.3300846009937406,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001995638,0.0004198308,0.001771578,0.00003794233,0.0001284926,0.00005122549,0.0002243473,0.001071786,0.00002047901],"category_scores_gemma":[0.00137795,0.0003194118,0.0009712131,0.0001144874,0.0002586191,0.00000704732,0.0001892631,0.0003416646,0.000008267207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002038567,"about_ca_system_score_gemma":0.0001434958,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":4.324683e-7,"about_ca_topic_score_gemma":0.000004387561,"domain_scores_codex":[0.9960986,0.0009465695,0.001698385,0.0007871485,0.00009722852,0.0003720188],"domain_scores_gemma":[0.997102,0.001214743,0.0009335511,0.0004198835,0.0001470688,0.0001827786],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000004874691,0.0003034259,0.0009105502,0.002638322,0.001160348,1.173188e-7,0.000001504979,1.907103e-9,3.252847e-7,0.00001884506,0.01051023,0.9844515],"study_design_scores_gemma":[0.0008427571,0.0007382684,0.00007138775,0.01414525,0.004048549,7.307775e-7,0.000004596061,0.000001188548,0.000001212171,0.0003288615,0.9794037,0.0004135066],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001048235,0.9957768,0.00007997915,0.001534128,0.0005214243,0.001512026,0.0003997317,0.00002307194,0.00004795977],"genre_scores_gemma":[0.0000403255,0.9946271,0.0002186777,0.002597529,0.0004299926,0.0005684334,0.0008225704,0.00008344463,0.0006119604],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9840379,"threshold_uncertainty_score":0.9999258,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063001046","doi":"10.1016/s0149-2918(02)85026-3","title":"Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis","year":2002,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":301,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Roche (Canada); PharmIdeas (Canada)","funders":"","keywords":"Dosing; Medicine; Pharmacotherapy; Internal medicine; Meta-analysis; Asymptomatic","retraction":null,"screen_n_in":null,"score":{"opus":0.8496116408869574,"gpt":0.5824938469086183,"spread":0.2671177939783391,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.001116943,0.0006452445,0.006095044,0.0002896697,0.0001229624,0.00007267707,0.0005916124,0.0006759798,0.002866513],"category_scores_gemma":[0.001013175,0.0004463679,0.002779674,0.001663171,0.0002973561,0.0001153374,0.00009346601,0.001386303,0.001831434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005486983,"about_ca_system_score_gemma":0.0003477299,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004664411,"about_ca_topic_score_gemma":0.000003600942,"domain_scores_codex":[0.9944387,0.0009947278,0.002287311,0.001265325,0.0006336034,0.0003803151],"domain_scores_gemma":[0.9878094,0.00866923,0.0009713594,0.001529598,0.000351867,0.0006685947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00003412567,0.0002058962,0.03245429,0.001205443,0.1258291,0.00004427733,0.0001525077,1.7251e-7,0.000001726151,0.00003614108,0.001437281,0.8385991],"study_design_scores_gemma":[0.0004451138,0.0004370864,0.00649298,0.001578848,0.5534257,0.000008473053,0.00001527209,0.00002809314,5.449326e-7,0.0002872892,0.4367996,0.0004809908],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003044946,0.9948026,0.001386769,0.001391277,0.0001744989,0.0014863,0.0001639828,0.00008523667,0.0002048484],"genre_scores_gemma":[0.001922973,0.982763,0.005020435,0.006385169,0.0005581679,0.0002244656,0.0001185658,0.00006599465,0.002941247],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8381181,"threshold_uncertainty_score":0.9997988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067874068","doi":"10.1016/s0149-2918(03)80164-9","title":"Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study","year":2003,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital","funders":"Abbott Laboratories","keywords":"Adalimumab; Medicine; Rheumatoid arthritis; Pharmacokinetics; Internal medicine; Placebo; Methotrexate; Pharmacology; Gastroenterology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.07058524546251149,"gpt":0.4150299238441398,"spread":0.3444446783816283,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002153325,0.0004552095,0.001578263,0.0002163418,0.0001923292,0.00007155663,0.0002315398,0.0001028558,0.0002139825],"category_scores_gemma":[0.0002570846,0.0003634307,0.0001603721,0.0004421884,0.0007111062,0.000141028,0.00009841796,0.0009590387,0.000003005856],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008990012,"about_ca_system_score_gemma":0.0005255703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001534851,"about_ca_topic_score_gemma":0.0002168643,"domain_scores_codex":[0.9947305,0.001264278,0.001797742,0.0007602576,0.0007687027,0.0006785608],"domain_scores_gemma":[0.9968764,0.001424167,0.0004377716,0.0005680661,0.0002913478,0.0004022192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005063859,0.008201131,0.9157338,0.0001059897,0.0009619102,0.0002580565,0.001073106,0.000008606089,0.0141618,0.0004127373,0.000007797322,0.05401124],"study_design_scores_gemma":[0.05511959,0.02501819,0.9130327,0.002049276,0.00003894462,0.0001548779,0.0007984209,0.0005226639,0.001346103,0.0001183855,0.00132481,0.0004760032],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922991,0.004474763,0.0003051439,0.0001697795,0.0001210772,0.002055822,0.00004832164,0.00006593387,0.0004600158],"genre_scores_gemma":[0.943732,0.0531733,0.002681301,0.000215771,0.00003202544,0.00004912851,0.00001974415,0.00007705779,0.00001969813],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05353524,"threshold_uncertainty_score":0.9998817,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976350400","doi":"10.1016/s0149-2918(00)89027-x","title":"Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus","year":2000,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":288,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Sirolimus; Medicine; Pharmacokinetics; Therapeutic drug monitoring; Pharmacology; Dosing; Tacrolimus; Ciclosporin; Immunosuppressive drug; Immunosuppression; Urology; Transplantation; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2801574483877703,"gpt":0.5272234146458807,"spread":0.2470659662581104,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007203375,0.0005278316,0.003371605,0.0001190544,0.0000498639,0.00001988476,0.0002126568,0.0005815658,0.00008074031],"category_scores_gemma":[0.00002176877,0.0003586619,0.001480944,0.0002219391,0.0003913392,0.0000228089,0.00003507586,0.00106129,0.00004288997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002628911,"about_ca_system_score_gemma":0.0002218803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001754476,"about_ca_topic_score_gemma":1.018562e-7,"domain_scores_codex":[0.9955145,0.0005357408,0.002710693,0.0005744509,0.0003479537,0.0003166917],"domain_scores_gemma":[0.9959232,0.00246538,0.0006559744,0.0005693485,0.00008495104,0.0003010993],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001446037,0.0006197192,0.02668722,0.007370049,0.002702993,0.00005357085,0.00002810734,2.447095e-7,1.255313e-7,0.00001513254,0.000005079767,0.9623731],"study_design_scores_gemma":[0.003174498,0.0006111166,0.005411702,0.01239668,0.01587304,0.0001043953,0.000009683717,0.00001814841,0.000002958553,0.00007169863,0.9619898,0.0003362588],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001304693,0.9961836,0.00001763771,0.00005145048,0.0008729236,0.0008615975,0.00005854045,0.00005198623,0.0005975221],"genre_scores_gemma":[0.001172372,0.9954889,0.001130707,0.0003799144,0.0007696665,0.00001969231,0.00005001813,0.0001038729,0.0008848361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9620369,"threshold_uncertainty_score":0.9998865,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1983297225","doi":"10.1016/s0149-2918(02)85038-x","title":"Therapeutic drug monitoring of immunosuppressant drugs in clinical practice","year":2002,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":286,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital; University of Toronto; Vancouver General Hospital; University Health Network; University of British Columbia","funders":"Novartis Pharmaceuticals Corporation","keywords":"Therapeutic drug monitoring; Medicine; Sirolimus; Tacrolimus; Everolimus; Dosing; Mycophenolate; Trough level; Pharmacology; Drug; Organ transplantation; Transplantation; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2676380036227732,"gpt":0.5240491652390866,"spread":0.2564111616163134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002110538,0.0005961691,0.004175679,0.0002073977,0.00004256806,0.00002663818,0.0003921509,0.000820738,0.00007452376],"category_scores_gemma":[0.0002445992,0.0004149258,0.002184398,0.00046018,0.0002905124,0.0001046016,0.00005909707,0.001921959,0.0001225385],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009723152,"about_ca_system_score_gemma":0.0003020953,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001095159,"about_ca_topic_score_gemma":3.466153e-7,"domain_scores_codex":[0.9921556,0.001393204,0.004742973,0.0006840887,0.0005992469,0.0004248797],"domain_scores_gemma":[0.98878,0.008325272,0.001485655,0.001013175,0.0001914274,0.0002044886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002059261,0.002319327,0.0183337,0.005945866,0.002919643,0.0001341005,0.0001464595,2.959224e-7,7.887088e-8,0.00006867959,0.000009871892,0.969916],"study_design_scores_gemma":[0.004017334,0.0006349228,0.007457172,0.02935489,0.01064011,0.0001278402,0.0001248959,0.00001678954,0.000002163471,0.00004806773,0.9471465,0.0004292683],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000234314,0.994994,0.00002150861,0.0001442058,0.001555052,0.001208184,0.00003406391,0.00004634418,0.001762337],"genre_scores_gemma":[0.001080198,0.9943385,0.002616135,0.0003356875,0.000511712,0.00004788028,0.00005586329,0.0001170622,0.0008970023],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9694868,"threshold_uncertainty_score":0.9998302,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2036061608","doi":"10.1016/j.clinthera.2009.07.022","title":"Inadequate pain management during routine childhood immunizations: The nerve of it","year":2009,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":284,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Mount Sinai Hospital; Western University; MASSolutions (Canada); Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University; University of Toronto","funders":"","keywords":"Medicine; CINAHL; Psychological intervention; PsycINFO; MEDLINE; Immunization; Cochrane Library; Physical therapy; Intensive care medicine; Pediatrics; Randomized controlled trial; Psychiatry; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1244260258490011,"gpt":0.4316911133279372,"spread":0.3072650874789361,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00533637,0.0004794373,0.002064355,0.0002620427,0.0001133637,0.00002883794,0.0008788906,0.0004569493,0.00003600217],"category_scores_gemma":[0.0004199891,0.0003133762,0.001101971,0.0009447302,0.0002092603,0.0000381506,0.0003340809,0.001085721,0.0000267932],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001139438,"about_ca_system_score_gemma":0.0001274583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002577802,"about_ca_topic_score_gemma":5.434292e-7,"domain_scores_codex":[0.9946879,0.001574476,0.00240986,0.0004829516,0.0004622768,0.0003825341],"domain_scores_gemma":[0.9955359,0.001410752,0.001132119,0.00172098,0.0001073244,0.00009294842],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001384205,0.0005528404,0.0001396432,0.005158245,0.001280225,0.00003247359,0.00002624591,7.499897e-7,3.037987e-8,0.0003297909,0.0008862874,0.9915797],"study_design_scores_gemma":[0.0007605266,0.0003681693,0.002237536,0.008368487,0.007459752,0.00001359033,0.00005721002,0.00004377927,3.398604e-7,0.0005913561,0.9797609,0.0003382876],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002224073,0.9902094,0.002356622,0.001345732,0.0001319409,0.002839109,0.00001055503,0.0002331385,0.002851231],"genre_scores_gemma":[0.0002268864,0.9922848,0.002844016,0.002785427,0.0004655784,0.00009786536,0.0001160006,0.00008690448,0.001092466],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9912413,"threshold_uncertainty_score":0.9999318,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2515998798","doi":"10.1016/j.clinthera.2016.07.010","title":"Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study","year":2016,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":278,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Teva Pharmaceutical Industries; Genentech; GlaxoSmithKline","keywords":"Mepolizumab; Medicine; Asthma; Term (time); Open label; Adverse effect; Internal medicine; Eosinophil","retraction":null,"screen_n_in":null,"score":{"opus":0.1029739026257499,"gpt":0.4248186128161392,"spread":0.3218447101903893,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003027233,0.0002305384,0.0006864909,0.00007008869,0.00005530999,0.00001598977,0.0002254692,0.0001275441,0.00003367286],"category_scores_gemma":[0.0001098319,0.0001265271,0.00005332572,0.0001531353,0.0003562294,0.0001036157,0.0001867735,0.0001985656,0.000007515701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004080392,"about_ca_system_score_gemma":0.0001509678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003077457,"about_ca_topic_score_gemma":0.00001443475,"domain_scores_codex":[0.9979078,0.0002636995,0.0008451356,0.0004416501,0.0002762776,0.0002654914],"domain_scores_gemma":[0.9984712,0.0003635566,0.0002436435,0.0005159473,0.0001514359,0.0002542439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01115902,0.05692878,0.7010384,0.00002835657,0.0001668723,0.00003888368,0.00009856489,6.701931e-8,0.00003228839,0.00000316685,0.000005395939,0.2305002],"study_design_scores_gemma":[0.2159802,0.01139642,0.7714766,0.0003668017,0.0001374442,0.000004505105,0.00003515496,0.000007132763,0.00001634627,0.000003241438,0.0004281591,0.0001479908],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974188,0.0003109005,0.00007879456,0.000173639,0.00009622967,0.001799928,0.00006027925,0.00002218594,0.00003924533],"genre_scores_gemma":[0.9988793,0.0001726045,0.0001911732,0.0005315755,0.00005753157,0.00001477139,0.00001179481,0.00003659766,0.0001046662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2303522,"threshold_uncertainty_score":0.5159624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114552474","doi":"10.1016/j.clinthera.2007.05.003","title":"Paroxetine and congenital malformations: Meta-Analysis and consideration of potential confounding factors","year":2007,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":229,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; University of Toronto; Western University; SickKids Foundation; Hospital for Sick Children","funders":"Novartis Pharmaceuticals Corporation; Pfizer","keywords":"Paroxetine; Medicine; Pregnancy; Confounding; Odds ratio; Obstetrics; Serotonin reuptake inhibitor; Depression (economics); Teratology; Pediatrics; Psychiatry; Gestation; Internal medicine; Antidepressant","retraction":null,"screen_n_in":null,"score":{"opus":0.462211290833294,"gpt":0.5250928676859848,"spread":0.06288157685269086,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001020852,0.000278754,0.003034716,0.0002142496,0.00007927832,0.00002906775,0.00005048458,0.0003899788,0.0001262217],"category_scores_gemma":[0.00009250721,0.0001853467,0.0009465417,0.0002118555,0.0002588025,0.00005289156,0.00004716398,0.0004337922,0.000003324718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001569635,"about_ca_system_score_gemma":0.00009458095,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001298846,"about_ca_topic_score_gemma":0.000005432679,"domain_scores_codex":[0.997314,0.0002700224,0.00175002,0.0002676899,0.0002124016,0.0001858889],"domain_scores_gemma":[0.997507,0.001219918,0.0007233595,0.0002456389,0.0001183328,0.0001856904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0004049865,0.0006395405,0.01111739,0.1164277,0.4490272,0.00008540339,0.000385365,8.095764e-7,8.955313e-7,0.001562866,0.00001239895,0.4203354],"study_design_scores_gemma":[0.0007699328,0.0005536248,0.001863012,0.002535522,0.8145972,0.0001529814,0.00005042952,0.00006670501,0.00001441958,0.00009168674,0.1789628,0.0003416459],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004306759,0.9941235,0.0003489148,0.00006130229,0.0002477649,0.0006990263,0.0001050368,0.00001766699,0.00009006054],"genre_scores_gemma":[0.01318493,0.9854465,0.000526915,0.0002988837,0.00008912247,0.00001198223,0.0001529836,0.00001983754,0.0002688139],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.4199938,"threshold_uncertainty_score":0.7558217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982550015","doi":"10.1016/j.clinthera.2009.07.023","title":"Psychological interventions for reducing pain and distress during routine childhood immunizations: A systematic review","year":2009,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Psychological intervention; Distress; Distraction; Randomized controlled trial; CINAHL; Physical therapy; PsycINFO; MEDLINE; Meta-analysis; Clinical psychology; Psychiatry; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2241223208121907,"gpt":0.513148059693282,"spread":0.2890257388810913,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005614686,0.0004522151,0.004132065,0.0001734591,0.0001272711,0.00004761739,0.0003903922,0.0004554435,0.00001268364],"category_scores_gemma":[0.004658875,0.0003260273,0.001837234,0.0004418371,0.0001177804,0.00003999464,0.0001291795,0.0007446646,0.00000567489],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008213231,"about_ca_system_score_gemma":0.00004085233,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":2.952497e-7,"about_ca_topic_score_gemma":1.29177e-7,"domain_scores_codex":[0.9940343,0.001693489,0.003133187,0.0006253776,0.0002032624,0.0003103652],"domain_scores_gemma":[0.9952508,0.00216249,0.001220133,0.001111075,0.0001176602,0.0001379076],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000004383243,0.0005701933,0.000013839,0.7020611,0.0005005882,0.000005862275,0.000004930485,1.747476e-8,1.167443e-8,0.0000402739,0.0001997748,0.296599],"study_design_scores_gemma":[0.0005293723,0.0007404582,0.0002012192,0.9508938,0.02116145,0.00006747693,0.000007434492,0.00002136333,1.180816e-8,0.0001713095,0.02586946,0.0003366048],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00000408215,0.9819334,0.008394652,0.0003561912,0.00009119426,0.008798837,0.0000389836,0.0002991218,0.00008355349],"genre_scores_gemma":[0.00003225759,0.9909038,0.005586777,0.001565932,0.0003140619,0.0008758928,0.0003428026,0.00006860836,0.0003098722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2962624,"threshold_uncertainty_score":0.9999192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085309918","doi":"10.1016/j.clinthera.2005.08.002","title":"Development and validity testing of the neuropathy total symptom score-6: Questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Korea Electrotechnology Research Institute; Eli Lilly and Company","keywords":"Medicine; Peripheral neuropathy; Construct validity; Cronbach's alpha; Convergent validity; Sensation; Intraclass correlation; Neuropathic pain; Diabetes mellitus; Diabetic neuropathy; Internal medicine; Physical therapy; Surgery; Patient satisfaction; Internal consistency; Psychometrics; Anesthesia; Clinical psychology; Endocrinology","retraction":null,"screen_n_in":null,"score":{"opus":0.1494490140932621,"gpt":0.3621678605428135,"spread":0.2127188464495514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008525207,0.0001610898,0.0004305472,0.00002208796,0.000114926,0.000006240437,0.0001382365,0.00007057725,0.000002454799],"category_scores_gemma":[0.000465392,0.0000890008,0.0001345225,0.0001289568,0.0002360909,0.00002355711,0.00009157402,0.0001850381,3.390089e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002105009,"about_ca_system_score_gemma":0.0001081888,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004781766,"about_ca_topic_score_gemma":0.000003818864,"domain_scores_codex":[0.998225,0.0003008655,0.0007955073,0.0002344156,0.0002760219,0.0001681553],"domain_scores_gemma":[0.9977314,0.001222788,0.0003640909,0.0004173084,0.0002038195,0.0000606122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00020915,0.002540127,0.805911,0.0001082928,0.0003149352,0.000003275271,0.00143278,0.00009054715,0.003412062,0.00009054579,0.000001349563,0.185886],"study_design_scores_gemma":[0.003184061,0.003497044,0.9802413,0.0002105944,0.0006929736,0.00001589786,0.0003179883,0.006897141,0.004641681,0.00007642974,0.0001214618,0.0001034037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979461,0.0003047004,0.0003224278,0.0001622138,0.0002354474,0.0009882379,0.000007201446,0.00001621894,0.00001742154],"genre_scores_gemma":[0.9973419,0.00003374778,0.002094606,0.000334458,0.0001029483,0.00002307058,7.810179e-7,0.00002396093,0.00004455031],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1857826,"threshold_uncertainty_score":0.3629347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075272700","doi":"10.1016/j.clinthera.2006.10.010","title":"Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: Baseline results from logic (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study","year":2006,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Novartis (Canada); University of British Columbia; Vancouver Coastal Health; Hôpital du Saint-Sacrement","funders":"","keywords":"Medicine; Irritable bowel syndrome; Constipation; Bloating; Quality of life (healthcare); Abdominal pain; Physical therapy; Internal medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.1287490962158889,"gpt":0.3780033189623475,"spread":0.2492542227464586,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002565844,0.0002711827,0.00164702,0.0001152646,0.00006259941,0.000006345964,0.0001414499,0.00005726194,0.000003063067],"category_scores_gemma":[0.001690074,0.000212723,0.00007125064,0.0006489889,0.0002715526,0.00004228578,0.00007011162,0.000539582,8.608104e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001901712,"about_ca_system_score_gemma":0.001642015,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6125227,"about_ca_topic_score_gemma":0.8009525,"domain_scores_codex":[0.9942991,0.001264251,0.002798576,0.0006212307,0.000666612,0.0003501946],"domain_scores_gemma":[0.9957691,0.001704902,0.00137932,0.0005673119,0.0003977394,0.0001816439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006261209,0.005158158,0.9859998,0.0003089324,0.0001325792,0.00002724494,0.0006690213,0.0006414034,0.000001902289,0.00001064325,0.00001569142,0.0007733706],"study_design_scores_gemma":[0.01041916,0.01170551,0.970279,0.00067807,0.0001301685,0.00002338949,0.006432532,0.000144753,0.000001197253,0.00006822096,0.000001032121,0.0001169487],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994713,0.001261237,0.00008775055,0.002048928,0.00004504694,0.001704399,0.0001038843,0.0000213,0.00001445681],"genre_scores_gemma":[0.9987091,0.000007377007,0.0009596607,0.0001631436,0.00001461089,0.000007085373,0.0001059771,0.00002137164,0.00001170241],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1884298,"threshold_uncertainty_score":0.8674594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105534073","doi":"10.1016/s0149-2918(03)80071-1","title":"Tramadol/Acetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study","year":2003,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":187,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Tramadol; Acetaminophen; Placebo; Discontinuation; Population; Analgesic; Randomized controlled trial; McGill Pain Questionnaire; Anesthesia; Visual analogue scale; Internal medicine; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2063443440781952,"gpt":0.4300767357906223,"spread":0.2237323917124271,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004745981,0.0003960686,0.001454878,0.00005838691,0.0002275229,0.00003712102,0.0003208059,0.0002636079,0.0003118968],"category_scores_gemma":[0.0001333828,0.000238809,0.0009595841,0.0001064594,0.0003909185,0.00007837517,0.00002152698,0.0002474033,0.00004728536],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001243373,"about_ca_system_score_gemma":0.00009986966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006410007,"about_ca_topic_score_gemma":0.000004880496,"domain_scores_codex":[0.993987,0.00336208,0.00152522,0.0004718625,0.0002309745,0.0004229122],"domain_scores_gemma":[0.9891964,0.009357251,0.0006047325,0.0005731293,0.0001735634,0.00009496728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9580854,0.02711373,0.001822775,0.0000519891,0.003329734,0.00003455166,0.001302629,0.0001198924,0.0001431148,0.0002540578,0.00005676048,0.007685383],"study_design_scores_gemma":[0.9221777,0.04079999,0.0002488559,0.00002591282,0.001849603,0.00001427355,0.0004355295,0.01678161,0.00007342979,0.0001031202,0.01721756,0.0002724742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9782976,0.001925369,0.002327951,0.0004687213,0.001486241,0.01525087,0.000009562175,0.00004564702,0.0001880574],"genre_scores_gemma":[0.9949424,0.0008567299,0.0002183688,0.0005759661,0.0001847958,0.002212545,0.0000129081,0.0000509453,0.0009453592],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03590773,"threshold_uncertainty_score":0.9738349,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2110145837","doi":"10.1016/j.clinthera.2006.11.006","title":"Remission versus response as the goal of therapy in ADHD: A new standard for the field?","year":2006,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":174,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan; Western University","funders":"","keywords":"Medicine; Field (mathematics); Psychotherapist; Clinical psychology","retraction":null,"screen_n_in":null,"score":{"opus":0.4098878550077667,"gpt":0.5730810218029107,"spread":0.163193166795144,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002551561,0.0002830238,0.001662473,0.00008041117,0.00005128648,0.00001152584,0.000379263,0.0005904066,0.0000986322],"category_scores_gemma":[0.002697265,0.0001369384,0.001243031,0.0003498239,0.000216934,0.00002262402,0.00005635232,0.0009003641,0.0000056677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005049656,"about_ca_system_score_gemma":0.001320319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002760996,"about_ca_topic_score_gemma":0.000008562191,"domain_scores_codex":[0.9969763,0.0007834488,0.001331282,0.0003060435,0.0003886349,0.0002142615],"domain_scores_gemma":[0.9656781,0.03238489,0.0007805963,0.0009301917,0.0001670604,0.00005916195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0146266,0.0002535027,0.00006062454,0.0005831504,0.0004391405,0.00000242639,0.0000687038,0.000001600672,0.000003108687,0.00006316509,0.001795607,0.9821024],"study_design_scores_gemma":[0.004120295,0.002740509,0.0001021793,0.002294279,0.001101351,0.000005973243,0.0001585022,0.00002003949,0.000005192842,0.0001375355,0.9891843,0.0001298081],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001692811,0.989437,0.0004759677,0.005230269,0.0006287469,0.002301355,0.0000320216,0.00001551858,0.0001862906],"genre_scores_gemma":[0.0004720268,0.9965618,0.0002381986,0.0007183384,0.0003607101,0.00004570953,0.00001717048,0.0000572785,0.001528779],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9873887,"threshold_uncertainty_score":0.5584184,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001129294","doi":"10.1016/j.clinthera.2005.08.001","title":"Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company; American Diabetes Association","keywords":"Medicine; Mesylate; Placebo; Peripheral neuropathy; Double blind; Protein kinase C; Peripheral; Clinical trial; Randomized controlled trial; Internal medicine; Pharmacology; Kinase; Diabetes mellitus; Endocrinology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.07598269146664982,"gpt":0.3738358848961089,"spread":0.297853193429459,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00242333,0.0005573567,0.002795499,0.00008317967,0.0001796497,0.00006005026,0.0002246197,0.0003107801,0.00009444095],"category_scores_gemma":[0.0002335017,0.0002692685,0.001490357,0.0001918317,0.0006687183,0.00007014803,0.00004994475,0.0004676173,0.00004059949],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000126432,"about_ca_system_score_gemma":0.0002758579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007017544,"about_ca_topic_score_gemma":0.000008280865,"domain_scores_codex":[0.9941664,0.001737331,0.002298967,0.0006536703,0.0005959258,0.0005477398],"domain_scores_gemma":[0.995541,0.002160784,0.0008252798,0.0009826788,0.00016211,0.0003281186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9799344,0.005738471,0.0008874887,0.00004765167,0.002575083,0.0001050032,0.0002329918,0.00001895767,0.0002529826,0.0002416998,0.000003553206,0.009961695],"study_design_scores_gemma":[0.980438,0.01110608,0.0003529465,0.000151749,0.003019367,0.0000249241,0.00007820411,0.00225357,0.001596914,0.00008734563,0.0006262334,0.0002646649],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984363,0.0007339508,0.0001971254,0.002382311,0.0003620439,0.01151502,0.000007986033,0.00009685406,0.0003417814],"genre_scores_gemma":[0.9924217,0.0005849234,0.001982782,0.000403179,0.001380359,0.001198304,0.00001036733,0.0000922106,0.001926213],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01031671,"threshold_uncertainty_score":0.999976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090003551","doi":"10.1016/s0149-2918(04)90002-1","title":"Osteoporosis in men: Epidemiology, diagnosis, prevention, and treatment","year":2004,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":168,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; University of British Columbia; Western University; Osteoporosis Canada; McMaster University; University of Saskatchewan; Université Laval; University of Calgary","funders":"Merck Canada","keywords":"Medicine; Osteoporosis; Vitamin D and neurology; Epidemiology; Bone density; Hip fracture; FRAX; Internal medicine; Pediatrics; Physical therapy; Bone mineral; Osteoporotic fracture","retraction":null,"screen_n_in":null,"score":{"opus":0.4133503429349107,"gpt":0.5670761980052973,"spread":0.1537258550703866,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003025973,0.0005062333,0.004283212,0.0002186751,0.00007719447,0.00001346568,0.0001562822,0.001301498,0.0000991667],"category_scores_gemma":[0.0008057319,0.000340935,0.0008893036,0.000358395,0.0004308221,0.00003262715,0.00009226023,0.001193294,0.00008819275],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005392914,"about_ca_system_score_gemma":0.00184912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008137825,"about_ca_topic_score_gemma":0.00006728835,"domain_scores_codex":[0.9939853,0.001543378,0.002734545,0.0008355431,0.0001982193,0.0007029978],"domain_scores_gemma":[0.9931198,0.004987251,0.0005134014,0.0007226536,0.00007595538,0.0005809582],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006091741,0.001072588,0.01371193,0.006430465,0.0002732418,0.00002876737,0.00002964294,7.048504e-8,6.918848e-9,0.00007160773,0.0001865186,0.9781343],"study_design_scores_gemma":[0.002611749,0.003110579,0.003892396,0.01400642,0.001266879,0.00005712724,0.00002385657,0.000003995597,1.627251e-7,0.000561529,0.9742162,0.0002490898],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001295312,0.9944369,0.000004547155,0.001908658,0.000217916,0.002863694,0.00003077268,0.00004210348,0.0003658376],"genre_scores_gemma":[0.00002253073,0.9953576,0.0009872451,0.001175334,0.0003467947,0.0008080859,0.0001786291,0.0000757688,0.001047992],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9778852,"threshold_uncertainty_score":0.999995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2969485794","doi":"10.1016/j.clinthera.2019.07.007","title":"Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study","year":2019,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"Johnson and Johnson; Roche; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Novartis; Sanofi; GlaxoSmithKline; Merck; Boehringer Ingelheim; Amgen; Pfizer; AstraZeneca","keywords":"Medicine; Mepolizumab; Asthma; Eosinophilic; Term (time); Intensive care medicine; Pediatrics; Dermatology; Internal medicine; Eosinophil; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.03179643496942163,"gpt":0.3498150675439138,"spread":0.3180186325744921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008886696,0.0002080937,0.000651037,0.00003259629,0.00008569771,0.00001693352,0.0002556194,0.0001670536,0.00005247062],"category_scores_gemma":[0.00007033478,0.00009325599,0.0001598054,0.0002224814,0.0006046274,0.00004348839,0.0001366109,0.0006003982,0.00001508078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002406471,"about_ca_system_score_gemma":0.0001548686,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007079092,"about_ca_topic_score_gemma":0.000053608,"domain_scores_codex":[0.9975724,0.0003999684,0.0009947496,0.0003720969,0.0004183431,0.0002424371],"domain_scores_gemma":[0.9972447,0.001335649,0.0003032468,0.0007984957,0.0001799953,0.0001378881],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002948516,0.002547672,0.9147559,0.00002264281,0.0002374243,0.000008148665,0.000151552,0.000005635106,7.093929e-7,0.00003072477,0.00001346606,0.0792776],"study_design_scores_gemma":[0.009642623,0.005673782,0.9823314,0.00008401045,0.00028213,0.000003746714,0.0003505452,0.0000454055,0.000001086703,0.00002221516,0.001436729,0.0001263192],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966451,0.0004906183,0.000005642051,0.0008214859,0.0001872703,0.001603873,0.00002073792,0.00001598686,0.0002093068],"genre_scores_gemma":[0.9969422,0.0002145243,0.00001369014,0.002450999,0.0001364201,0.000006245721,0.000009963263,0.00003012803,0.0001957841],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07915128,"threshold_uncertainty_score":0.3802869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2010788192","doi":"10.1016/j.clinthera.2005.11.020","title":"Postprandial glucose regulation: New data andnew implications","year":2005,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Takeda Pharmaceuticals North America; Novartis Pharmaceuticals Corporation; Unilever; Amylin Pharmaceuticals; Bayer; AstraZeneca; Novo Nordisk; Sanofi","keywords":"Postprandial; Medicine; Internal medicine; Glycemic; Endocrinology; Type 2 diabetes; Diabetes mellitus; Insulin; Basal (medicine); Insulin glargine","retraction":null,"screen_n_in":null,"score":{"opus":0.5155880908997695,"gpt":0.5286185095723552,"spread":0.0130304186725857,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001589584,0.0005620896,0.003395651,0.0001316237,0.0001223359,0.00008956034,0.0009891464,0.001063425,0.000335256],"category_scores_gemma":[0.0003888206,0.0004384648,0.002029562,0.0004611885,0.0002402451,0.000131702,0.0003431672,0.001170431,0.0005767904],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009316446,"about_ca_system_score_gemma":0.001733029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007139515,"about_ca_topic_score_gemma":0.00004856617,"domain_scores_codex":[0.9956515,0.000437124,0.001892732,0.001089832,0.0004698702,0.0004589529],"domain_scores_gemma":[0.9930643,0.0007811682,0.0005484198,0.004901695,0.0001476284,0.0005568196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005127319,0.0002488419,0.00001254069,0.0008741764,0.002154861,0.000004167502,0.000009215972,1.937777e-7,2.702205e-8,0.00007623314,0.006199446,0.990369],"study_design_scores_gemma":[0.001555488,0.0003437618,0.000825347,0.0025952,0.01192966,0.0001069988,0.000002361721,0.0000179104,1.408276e-7,0.0002175871,0.9819729,0.0004326297],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000003012616,0.9922548,0.001082917,0.001160248,0.001076058,0.00190188,0.000257878,0.0001766382,0.002086591],"genre_scores_gemma":[0.000006818134,0.9742615,0.003895873,0.001532991,0.01484339,0.00003688502,0.003320782,0.0001518293,0.001949964],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9899364,"threshold_uncertainty_score":0.9998067,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131931738","doi":"10.1016/j.clinthera.2006.09.021","title":"Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization","year":2006,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":159,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Persistence (discontinuity); Medicine; Medical prescription; Terminology; MEDLINE; Ranking (information retrieval); Intensive care medicine; Pharmacology; Information retrieval; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.9320255751568463,"gpt":0.5942286578077858,"spread":0.3377969173490605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002683847,0.0004097868,0.00174795,0.0001601413,0.0001038431,0.00005659261,0.0002137294,0.0003543883,0.000008217701],"category_scores_gemma":[0.0005977614,0.0002750382,0.0001520768,0.0002676471,0.0008247433,0.00007065561,0.00008349863,0.0007766195,0.000001018718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001130427,"about_ca_system_score_gemma":0.0002921453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002489771,"about_ca_topic_score_gemma":0.00002404002,"domain_scores_codex":[0.9957798,0.001213128,0.001113879,0.0006353129,0.0009709367,0.0002870004],"domain_scores_gemma":[0.991731,0.005863877,0.0006816724,0.0005418019,0.001097207,0.00008439696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002044562,0.0002276804,0.00005229759,0.002045794,0.0003065183,0.000007051502,0.0002585457,1.416237e-7,0.000003303021,0.007107024,0.0001355638,0.9896516],"study_design_scores_gemma":[0.001939245,0.00499556,0.0001295238,0.03429849,0.001639639,0.00001679685,0.001335502,0.00003740573,0.0002574101,0.3115118,0.6426866,0.001151982],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001094998,0.9831338,0.01348412,0.00006626567,0.00004452115,0.001526858,0.0002855425,0.0001009345,0.0002629508],"genre_scores_gemma":[0.001667013,0.9622191,0.03576398,0.00007736729,0.00005946412,0.00006712125,0.00005520157,0.00007950234,0.0000112722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9884996,"threshold_uncertainty_score":0.9999702,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2013547083","doi":"10.1016/j.clinthera.2009.07.024","title":"Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: Systematic review of randomized controlled trials and quasi-randomized controlled trials","year":2009,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto; Institute for Clinical Evaluative Sciences; SickKids Foundation; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Sanofi Pasteur","keywords":"Medicine; Randomized controlled trial; Psychological intervention; Placebo; Physical therapy; Intramuscular injection; CINAHL; Subcutaneous injection; Clinical trial; Vaccine efficacy; Injection site; Vaccination; Anesthesia; Surgery; Internal medicine; Alternative medicine; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.1063178432050238,"gpt":0.4688474361080228,"spread":0.362529592902999,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.2146919,0.0008965409,0.09297648,0.0007239501,0.0002695362,0.0001191166,0.0001513704,0.0008040653,0.00001259612],"category_scores_gemma":[0.3173893,0.0004693208,0.02603659,0.000491031,0.0004179561,0.00009172576,0.00004897144,0.0008883284,8.01553e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001173086,"about_ca_system_score_gemma":0.0002994437,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008780115,"about_ca_topic_score_gemma":7.086838e-7,"domain_scores_codex":[0.9130793,0.06775967,0.01778377,0.0006437195,0.0004174547,0.000316047],"domain_scores_gemma":[0.8292823,0.153008,0.01558209,0.0008772868,0.001074097,0.0001762497],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.2090257,0.001345865,1.501072e-7,0.6541424,0.03042842,0.000001069296,0.00009444091,0.000001123048,0.000003301289,0.0004894882,0.00001294818,0.104455],"study_design_scores_gemma":[0.4176602,0.001055448,1.695832e-7,0.4305186,0.1492509,0.00007462518,0.00002613646,0.0007738515,0.000002514686,0.0003230528,0.00009557052,0.0002189354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005214171,0.8888954,0.02374758,0.000187304,0.0004320832,0.08647983,0.00002916288,0.000141923,0.00003456478],"genre_scores_gemma":[0.0007093869,0.9838027,0.001399712,0.000219849,0.0009531085,0.01248734,0.0001678482,0.00009645801,0.0001636478],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.2236238,"threshold_uncertainty_score":0.9997758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146831409","doi":"10.1016/s0149-2918(02)85139-6","title":"A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"Abbott Laboratories","keywords":"Medicine; Gemifloxacin; Chronic bronchitis; Clarithromycin; Exacerbation; Bronchitis; Regimen; Internal medicine; Respiratory tract infections; Randomized controlled trial; Sputum; Lower respiratory tract infection; Antibacterial agent; Antibiotics; Tuberculosis; Respiratory system","retraction":null,"screen_n_in":null,"score":{"opus":0.1845412847857562,"gpt":0.4779295199573555,"spread":0.2933882351715993,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004391598,0.0001438809,0.00093941,0.00009723657,0.00004303173,0.000007170097,0.00006853126,0.0003280901,0.00007014586],"category_scores_gemma":[0.0001097408,0.0001153931,0.0001887216,0.0001690125,0.0007365973,0.00004472196,0.00005659442,0.0005746835,0.000004047274],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002302302,"about_ca_system_score_gemma":0.00005554632,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004965517,"about_ca_topic_score_gemma":0.00007158763,"domain_scores_codex":[0.9978306,0.0002035557,0.001386589,0.0002587391,0.000144008,0.0001764695],"domain_scores_gemma":[0.9982318,0.0009778042,0.0002667877,0.0003189789,0.00006929125,0.0001353992],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00002786571,0.00133695,0.958622,0.00006465743,0.0003284113,0.000006461002,0.0001262473,0.000003200363,0.001123568,0.0001066785,0.00002453823,0.03822947],"study_design_scores_gemma":[0.003142042,0.001764009,0.9920677,0.0001357181,0.0004329863,0.00002092562,0.00003557427,0.001432415,0.0001237827,0.00006696443,0.0006728943,0.0001049854],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956257,0.001937921,0.0002551812,0.001464862,0.0002033923,0.0003082516,0.00001418829,0.00002028234,0.0001702343],"genre_scores_gemma":[0.9929243,0.005946819,0.000178073,0.00069658,0.00008203969,0.000006154323,0.000003715833,0.00001606838,0.0001462917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03812448,"threshold_uncertainty_score":0.4705594,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2076423044","doi":"10.1016/s0149-2918(00)80058-2","title":"Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure","year":2000,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"National Institute on Drug Abuse; Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Medication adherence; Construct validity; Psychological intervention; Predictive validity; Physical therapy; Clinical psychology; Psychometrics; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.3722121435493425,"gpt":0.4488118181916646,"spread":0.07659967464232215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003882962,0.00007508859,0.0002399764,0.00001998968,0.0000288241,0.000002405081,0.00006616348,0.00006247176,0.00008814111],"category_scores_gemma":[0.00007041452,0.00005538001,0.00003799182,0.00007470286,0.0001654003,0.00003280794,0.00000471798,0.0000556136,0.0000025249],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001297108,"about_ca_system_score_gemma":0.0003558192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001466306,"about_ca_topic_score_gemma":0.00000126357,"domain_scores_codex":[0.9990844,0.0000280796,0.0004213999,0.0001734352,0.0001949875,0.00009774828],"domain_scores_gemma":[0.9990346,0.0002411863,0.00021684,0.0002107639,0.0001972249,0.00009932763],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.001535016,0.0003762892,0.03328979,0.0008043484,0.0001914793,2.83948e-7,0.0003603826,0.000001166037,0.000574817,0.000381048,0.0001626036,0.9623228],"study_design_scores_gemma":[0.02329658,0.01218758,0.6767509,0.005288956,0.001912504,0.000008126296,0.0003689297,0.006967449,0.048387,0.001671429,0.2224598,0.0007007147],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9555451,0.005203645,0.03189972,0.00368887,0.00009760213,0.003239311,0.00005084872,0.00003689167,0.0002380508],"genre_scores_gemma":[0.9866113,0.00125837,0.01036563,0.0005640911,0.0001042917,0.0003618819,0.00007596299,0.00001217015,0.0006462635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9616221,"threshold_uncertainty_score":0.2258331,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019005588","doi":"10.1016/j.clinthera.2009.08.001","title":"Effectiveness and tolerability of pharmacologic and combined interventions for reducing injection pain during routine childhood immunizations: Systematic review and meta-analyses","year":2009,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Western University; Mount Sinai Hospital","funders":"","keywords":"Medicine; Tolerability; Placebo; Analgesic; Psychological intervention; Systematic review; Acetaminophen; Meta-analysis; Randomized controlled trial; Clinical trial; MEDLINE; Adverse effect; Anesthesia; Physical therapy; Surgery; Internal medicine; Alternative medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.3380204177131069,"gpt":0.5405198797280191,"spread":0.2024994620149122,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0103637,0.0003569792,0.005984561,0.0001943277,0.00009879989,0.00002310255,0.0001242049,0.0002393332,0.00000606742],"category_scores_gemma":[0.003551554,0.0002430247,0.001145676,0.0003756064,0.0001562765,0.00005594398,0.0001113149,0.0003804534,1.340888e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006162015,"about_ca_system_score_gemma":0.00004899185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000209354,"about_ca_topic_score_gemma":1.923752e-7,"domain_scores_codex":[0.9929313,0.003930499,0.002392191,0.0004694088,0.0001259878,0.0001505959],"domain_scores_gemma":[0.9932207,0.004708563,0.001341377,0.0004728839,0.0001831252,0.00007328439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.0000183174,0.0004548526,0.00009174566,0.9579932,0.009394742,7.399128e-7,0.000009680218,2.761661e-7,0.000001329154,0.00001434024,0.000006765275,0.03201402],"study_design_scores_gemma":[0.001265618,0.001899238,0.003188527,0.2864704,0.7058821,0.00003744642,0.00001559311,0.0000907624,0.000003070149,0.0004691687,0.0003123891,0.0003656777],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003321074,0.9863186,0.003905993,0.000104165,0.00002851891,0.009192886,0.00002344288,0.00008869683,0.000005524123],"genre_scores_gemma":[0.003642042,0.9939327,0.001381307,0.0002250621,0.0000320772,0.0006818805,0.00004761302,0.00002953168,0.00002777745],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6964874,"threshold_uncertainty_score":0.9910257,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1757837840","doi":"10.1016/j.clinthera.2015.09.008","title":"Trends in Prescribing Oral Anticoagulants in Canada, 2008–2014","year":2015,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":144,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia; Bayer (Canada); McGill University Health Centre; Regina Qu'Appelle Health Region; McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"Daiichi Sankyo Europe; Bayer Canada; Health Canada; Daiichi-Sankyo; Centro para el Desarrollo Tecnológico Industrial","keywords":"Medicine; Apixaban; Rivaroxaban; Medical prescription; Dabigatran; Warfarin; Vitamin K antagonist; Specialty; Reimbursement; Emergency medicine; Family medicine; Internal medicine; Atrial fibrillation; Pharmacology; Health care","retraction":null,"screen_n_in":null,"score":{"opus":0.4284872103572043,"gpt":0.4656241182411223,"spread":0.03713690788391794,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007499401,0.0001046182,0.000442374,0.0001341975,0.00001087673,0.000009931686,0.00008219882,0.00008503867,0.00007250296],"category_scores_gemma":[0.0001284755,0.00008708622,0.00007691079,0.000286276,0.00003470234,0.00004650119,0.00004224232,0.0002100263,0.00001900112],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001683867,"about_ca_system_score_gemma":0.0003595779,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.08213776,"about_ca_topic_score_gemma":0.3922215,"domain_scores_codex":[0.9985853,0.0001276112,0.0006139142,0.000190706,0.0002460668,0.0002363586],"domain_scores_gemma":[0.9993313,0.0002035599,0.00007807718,0.0002189124,0.00003571522,0.0001324161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001457171,0.00001862556,0.9483953,0.000003908566,0.00003263632,0.00004051133,0.00004144987,0.00007710027,0.000005157173,0.00006281422,0.002323646,0.04885317],"study_design_scores_gemma":[0.003308381,0.00009851326,0.935557,0.00002775992,0.00004772277,0.000001716494,0.0001320591,0.005386495,0.00001191097,0.0001392864,0.05518308,0.0001060981],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897227,0.0004412223,0.00005100533,0.005434762,0.0007451146,0.0001758584,0.000002237172,0.00002312908,0.003404011],"genre_scores_gemma":[0.9957371,0.0001371085,0.0003695278,0.001885177,0.0003103778,5.952186e-7,0.00001578462,0.00001382581,0.001530466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3100838,"threshold_uncertainty_score":0.9239743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105482790","doi":"10.1016/s0149-2918(04)90171-3","title":"A treatment algorithm for neuropathic pain","year":2004,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba; Health Sciences Centre; Manitoba Health","funders":"","keywords":"Medicine; Neuropathic pain; Drug class; Pregabalin; Drug; Chronic pain; MEDLINE; Intensive care medicine; Anesthesia; Physical therapy; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.305997592243914,"gpt":0.495687724004519,"spread":0.189690131760605,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001850485,0.000591018,0.002792506,0.00008067499,0.00008545633,0.00002406173,0.0001503437,0.0007383496,0.00002142778],"category_scores_gemma":[0.0002227938,0.0003692679,0.002289025,0.0001477272,0.00008911184,0.0000137672,0.00002694452,0.0004074209,0.00009933689],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003173529,"about_ca_system_score_gemma":0.0008974735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002246145,"about_ca_topic_score_gemma":3.290019e-7,"domain_scores_codex":[0.9966246,0.0009621775,0.001157471,0.000658955,0.0001896863,0.0004070478],"domain_scores_gemma":[0.9957547,0.002818491,0.0003743299,0.0007157571,0.00007874709,0.0002580073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001667428,0.001282207,0.000003043867,0.002644411,0.00147119,0.000153892,0.000007820735,3.253574e-8,2.85205e-8,0.0001272484,0.00001110997,0.9942824],"study_design_scores_gemma":[0.002652054,0.005304605,0.000001099242,0.005929363,0.008437996,0.00009079932,0.000003143364,0.0005233141,3.78585e-7,0.0006720826,0.9761112,0.0002739884],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[1.795373e-7,0.9408462,0.05536947,0.0001011417,0.0006113455,0.002769385,0.0001194127,0.0001025411,0.0000803034],"genre_scores_gemma":[6.538635e-7,0.9676107,0.02814637,0.001100519,0.0007693103,0.0004680549,0.0003043676,0.00015194,0.001448069],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9940084,"threshold_uncertainty_score":0.9998759,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2098903681","doi":"10.1016/j.clinthera.2005.06.018","title":"Analgesia and local anesthesia during invasive procedures in the neonate","year":2005,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pediatric Pain Management Techniques","field":"Medicine","cited_by":134,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Hospital for Sick Children; Population Health Research Institute; SickKids Foundation; BC Children's Hospital; McGill University","funders":"","keywords":"Medicine; Venipuncture; Neonatal intensive care unit; MEDLINE; Intensive care medicine; Randomized controlled trial; Pain assessment; Cochrane Library; Clinical trial; Pediatrics; Anesthesia; Pain management; Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.1315547836949508,"gpt":0.4365234261927203,"spread":0.3049686424977694,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001742926,0.0004251988,0.00163832,0.0002435069,0.00005829192,0.0000425805,0.0004594356,0.0005908685,0.00001090564],"category_scores_gemma":[0.0003231498,0.0002647174,0.0004192289,0.0004983963,0.0003609513,0.0000470577,0.00009683165,0.001221818,0.0000183315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009009261,"about_ca_system_score_gemma":0.0004230143,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000284064,"about_ca_topic_score_gemma":0.00001540745,"domain_scores_codex":[0.9968332,0.0006908189,0.001229358,0.0005460109,0.0003371392,0.0003634449],"domain_scores_gemma":[0.9967823,0.002027252,0.0003917717,0.0006549098,0.00004220735,0.0001015755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003477397,0.0002057672,0.001707354,0.008630329,0.0002101824,0.0004810939,0.00005744199,1.887881e-7,4.939996e-8,0.0000771722,0.0003119424,0.9882837],"study_design_scores_gemma":[0.0005820775,0.0002316356,0.007628678,0.005829523,0.002311096,0.0004967522,0.00005731072,0.00001443378,1.564313e-7,0.0001977104,0.9823185,0.0003321063],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006957382,0.9959181,0.00006585427,0.0009982901,0.00002580801,0.00180776,0.000001583345,0.0001233422,0.0003635225],"genre_scores_gemma":[0.001535628,0.9930509,0.0005707935,0.003855195,0.0006292108,0.000132371,0.00001624154,0.00006356248,0.0001460811],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9879516,"threshold_uncertainty_score":0.9999805,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079614274","doi":"10.1016/s0149-2918(03)80068-1","title":"A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus","year":2003,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Diabetes Canada; Ottawa Hospital","funders":"Eli Lilly and Company","keywords":"Pioglitazone; Medicine; Internal medicine; Placebo; Dyslipidemia; Glycemic; Diabetes mellitus; Thiazolidinedione; Glycated hemoglobin; Type 2 diabetes; Type 2 Diabetes Mellitus; Gastroenterology; Endocrinology; Insulin","retraction":null,"screen_n_in":null,"score":{"opus":0.03897713012726592,"gpt":0.3408353580148224,"spread":0.3018582278875565,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006276206,0.0003465529,0.003557989,0.0001292623,0.00004963355,0.00001146173,0.0002354861,0.0005105052,0.00001013818],"category_scores_gemma":[0.006530134,0.0001922054,0.001026901,0.0003588607,0.001353998,0.00005081249,0.0000362155,0.0008608319,0.000004410259],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003689305,"about_ca_system_score_gemma":0.0003310194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004511415,"about_ca_topic_score_gemma":0.00001803737,"domain_scores_codex":[0.9933262,0.002734545,0.002295529,0.0005225123,0.0007335172,0.0003876956],"domain_scores_gemma":[0.9869539,0.01063907,0.000929779,0.0009154498,0.0003625013,0.0001992608],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9094104,0.001809741,0.0620446,0.0001379363,0.002975444,0.000001802618,0.00006585473,0.000007051995,0.000008423077,0.000175364,0.00001381008,0.02334953],"study_design_scores_gemma":[0.9733028,0.008022208,0.01366244,0.0005003414,0.003170871,6.944434e-7,0.0000205999,0.0001635189,0.0001643401,0.0002840532,0.0005103264,0.000197762],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9860525,0.004203166,0.00006359104,0.0001677759,0.001466803,0.007770158,0.000007114352,0.00002008156,0.0002488425],"genre_scores_gemma":[0.9960253,0.002318611,0.0002055365,0.0009240964,0.0002462646,0.0001888147,0.00001084057,0.0000461942,0.00003435968],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0638924,"threshold_uncertainty_score":0.7837908,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067175073","doi":"10.1016/j.clinthera.2010.04.018","title":"Buprenorphine transdermal system in adults with chronic low back pain: A randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase","year":2010,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; London Health Sciences Centre; University of Alberta; Hôpital Fleurimont","funders":"Purdue Pharma","keywords":"Medicine; Placebo; Buprenorphine; Visual analogue scale; Anesthesia; Crossover study; Tolerability; Opioid; Analgesic; Randomized controlled trial; Transdermal patch; Oxycodone; Randomization; Transdermal; Adverse effect; Surgery; Internal medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.06105664667301164,"gpt":0.3933878888950649,"spread":0.3323312422220533,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005628123,0.0006858197,0.003121808,0.0001272623,0.0001547418,0.000176373,0.0005722999,0.0005067391,0.0001675668],"category_scores_gemma":[0.0001563831,0.0004437116,0.0003108344,0.0003542661,0.0003988884,0.0002670291,0.00008953467,0.001216753,0.00006264777],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001574328,"about_ca_system_score_gemma":0.0005563934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001868472,"about_ca_topic_score_gemma":0.0007927712,"domain_scores_codex":[0.9939734,0.001408291,0.002095145,0.001174481,0.0006425601,0.0007061005],"domain_scores_gemma":[0.9955232,0.001771283,0.0004962314,0.001437425,0.0002972392,0.0004746487],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9467447,0.03924536,0.003152459,0.0002542046,0.001523161,0.0002016493,0.00109449,0.00001768895,0.0009745967,0.00002819387,0.00008479132,0.006678706],"study_design_scores_gemma":[0.9518661,0.01442468,0.0002039447,0.000661651,0.001428519,0.00002625547,0.000573391,0.02986123,0.0001465389,0.00000895731,0.0003195484,0.0004791147],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9744294,0.001167548,0.0007124452,0.000776381,0.0005569659,0.02193151,0.00003445759,0.0001345531,0.0002567661],"genre_scores_gemma":[0.9954547,0.0002045859,0.0006526434,0.001053803,0.0002801085,0.001520889,0.0002056581,0.0001482475,0.0004794182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02984354,"threshold_uncertainty_score":0.9998015,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050776171","doi":"10.1016/j.clinthera.2007.05.007","title":"Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia","year":2007,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Deferasirox; Medicine; Deferoxamine; Thalassemia; Deferiprone; Beta thalassemia; Chelation therapy; Pediatrics; Internal medicine; Prospective cohort study; Adverse effect; Quality of life (healthcare); Surgery","retraction":null,"screen_n_in":null,"score":{"opus":0.05687604124416545,"gpt":0.3762289759901872,"spread":0.3193529347460217,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005636816,0.0002264159,0.0005615957,0.00009591941,0.00004601466,0.000005743088,0.00004273347,0.0002164185,0.000015508],"category_scores_gemma":[0.0001536362,0.0001199266,0.0001161636,0.0002436661,0.0001234877,0.0000488677,0.00001161941,0.0001793455,8.630566e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003118557,"about_ca_system_score_gemma":0.0002233776,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000109582,"about_ca_topic_score_gemma":0.0001010894,"domain_scores_codex":[0.9979135,0.00006337542,0.0008640703,0.0003430368,0.0005193613,0.0002966445],"domain_scores_gemma":[0.9983999,0.0003338394,0.0003614828,0.0003182901,0.0004842143,0.0001023304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01235302,0.002980815,0.9527578,0.00004166086,0.0005519761,0.00001012737,0.0004207645,0.0000552219,0.00005051011,0.000006810077,6.653227e-7,0.03077063],"study_design_scores_gemma":[0.03576123,0.01220743,0.9492146,0.0001485564,0.001068056,0.000004587685,0.0004183134,0.0001525108,0.0007653418,0.00002849053,0.00007345535,0.0001574447],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965823,0.0001315976,0.00007953808,0.00006478636,0.00008697256,0.002825149,0.000008113338,0.00002698633,0.0001945746],"genre_scores_gemma":[0.9985559,0.00007828038,0.000999833,0.0001198503,0.00001986208,0.00006117577,0.00003704454,0.00003789358,0.00009016716],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03061318,"threshold_uncertainty_score":0.4890463,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143462158","doi":"10.1016/s0149-2918(03)80122-4","title":"Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000","year":2003,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Indirect costs; Emergency medicine; Intensive care medicine; Cost database; Microalbuminuria; Macrovascular disease; Complication; Type 2 diabetes; Health care; Surgery; Endocrinology; Database","retraction":null,"screen_n_in":null,"score":{"opus":0.06930654272877787,"gpt":0.3747194924125226,"spread":0.3054129496837447,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001637023,0.0001257558,0.000411136,0.00008589532,0.00003282608,0.00001499938,0.0001202924,0.0001096443,0.00001418195],"category_scores_gemma":[0.0007022964,0.00008504884,0.0001069237,0.0003280701,0.0001958103,0.00002143873,0.00002475354,0.0001621988,0.000002325505],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003167784,"about_ca_system_score_gemma":0.00004918209,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009576013,"about_ca_topic_score_gemma":0.00004541455,"domain_scores_codex":[0.9985552,0.000239421,0.000558844,0.0002391809,0.0001899348,0.0002173817],"domain_scores_gemma":[0.9964035,0.003026977,0.00008689476,0.0003427779,0.00007703315,0.00006280818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002247658,0.002856011,0.8645623,0.0001814489,0.00188991,0.00001721366,0.001078046,0.00007031817,0.0003105332,0.001591843,0.0003927519,0.1268249],"study_design_scores_gemma":[0.02329865,0.001977634,0.5797579,0.001434542,0.002565867,0.000002840324,0.00170606,0.04900862,0.005485476,0.01166128,0.3224624,0.000638804],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875876,0.009383669,0.0001479798,0.001661775,0.00006704628,0.0007874437,0.0000148111,0.00001766676,0.0003320505],"genre_scores_gemma":[0.9793381,0.01002932,0.006504038,0.003552853,0.00003142471,0.0000687858,0.0004255949,0.00002605756,0.00002382367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3220696,"threshold_uncertainty_score":0.3468191,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2325862423","doi":"10.1016/j.clinthera.2016.03.008","title":"Patient-reported Symptoms of Tenosynovial Giant Cell Tumors","year":2016,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Musculoskeletal synovial abnormalities and treatments","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Daiichi Sankyo Europe; National Cancer Institute; Plexxikon; Five Prime Therapeutics","keywords":"Medicine; Clinical significance; Ankle; Elbow; Physical therapy; Forearm; Internal medicine; Surgery; Oncology","retraction":null,"screen_n_in":null,"score":{"opus":0.05029915522095849,"gpt":0.3410632115145139,"spread":0.2907640562935553,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002169146,0.0001846511,0.0005361739,0.00004207994,0.00003728732,0.000005095715,0.00008640156,0.0001662749,0.0002538959],"category_scores_gemma":[0.00007820283,0.00009999345,0.000402436,0.000113229,0.0002910225,0.00004476249,0.00005975056,0.0001329542,0.00003480673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000359456,"about_ca_system_score_gemma":0.0001213472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001951035,"about_ca_topic_score_gemma":0.000001332433,"domain_scores_codex":[0.9979656,0.00008240739,0.001064424,0.0002834401,0.000311161,0.0002930004],"domain_scores_gemma":[0.9984844,0.0003264256,0.0003509929,0.0004815839,0.0001505153,0.0002060482],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0008759487,0.002548595,0.3694908,0.00009683744,0.0008531808,0.0001416482,0.000091619,2.664184e-7,0.01124031,0.0006624814,0.0001309174,0.6138673],"study_design_scores_gemma":[0.03268437,0.02879697,0.7233343,0.001245542,0.002673322,0.0002042391,0.0002451482,0.0001181717,0.07655013,0.002493615,0.1304231,0.001231111],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925596,0.0002071084,0.0001875536,0.0005944323,0.0004231534,0.0003544063,0.00002501879,0.00005341834,0.005595343],"genre_scores_gemma":[0.9967678,0.0001871671,0.0003717556,0.0008630136,0.0001908728,0.000008280997,0.000009305885,0.00003051903,0.001571291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6126363,"threshold_uncertainty_score":0.4077615,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2018295858","doi":"10.1016/j.clinthera.2010.01.021","title":"Aripiprazole in schizophrenia and schizoaffective disorder: A review","year":2010,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Hôpital Louis-H Lafontaine","funders":"Université de Montréal; Pfizer; AstraZeneca Canada; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Aripiprazole; Schizoaffective disorder; Tolerability; Medicine; Schizophrenia (object-oriented programming); Atypical antipsychotic; Psychiatry; Antipsychotic; Adverse effect; Tardive dyskinesia; Psychosis; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1369497567409218,"gpt":0.4843338219404982,"spread":0.3473840651995764,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001102088,0.0005413027,0.003228169,0.0002253861,0.00004951837,0.00002945785,0.0002114925,0.0007510833,0.0001953325],"category_scores_gemma":[0.0005732403,0.0003589085,0.0007463549,0.0004828074,0.000357348,0.00003360731,0.0001587272,0.00266141,0.0003272712],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006290598,"about_ca_system_score_gemma":0.0008101215,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001013642,"about_ca_topic_score_gemma":0.0001268236,"domain_scores_codex":[0.9967192,0.0005178144,0.001267194,0.0007480895,0.0003074592,0.000440232],"domain_scores_gemma":[0.9971818,0.001145576,0.0003354689,0.0008627931,0.00005802663,0.0004162807],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004036679,0.0005332895,0.000403495,0.01101939,0.0004211961,0.0001082643,0.000002400606,1.365922e-9,3.469827e-8,0.0003962349,0.00007758479,0.9866344],"study_design_scores_gemma":[0.003276818,0.0005543643,0.0008607091,0.04490362,0.00211274,0.0001582901,0.00000168917,0.000005618993,8.051725e-8,0.0002952335,0.9475415,0.0002893106],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007816989,0.9948127,0.000007050599,0.0004624975,0.0001810093,0.002933535,0.00001864786,0.00006967696,0.001436704],"genre_scores_gemma":[0.00001062592,0.9959343,0.002104274,0.0005631204,0.0002767922,0.0002616194,0.00005590521,0.0001497106,0.0006436675],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9863451,"threshold_uncertainty_score":0.9998863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2026253267","doi":"10.1016/s0149-2918(02)85024-x","title":"Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: a multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Veterinary Pharmacology and Anesthesia","field":"Veterinary","cited_by":106,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University","keywords":"Medicine; Tramadol; Placebo; Osteoarthritis; Acetaminophen; Randomized controlled trial; Double blind; Anesthesia; Physical therapy; Analgesic; Internal medicine; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2380535386634497,"gpt":0.4155108502229706,"spread":0.1774573115595209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002844333,0.0004668076,0.001563919,0.00008415616,0.0003444366,0.00005313785,0.0004195158,0.0003192461,0.0002875259],"category_scores_gemma":[0.000120182,0.0002969376,0.001025615,0.0001159515,0.0003914456,0.0001053473,0.00003363228,0.000325219,0.0000532429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000624252,"about_ca_system_score_gemma":0.00001608183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007981224,"about_ca_topic_score_gemma":0.000009702416,"domain_scores_codex":[0.9942244,0.002850729,0.001587965,0.0005677352,0.0003079149,0.0004612772],"domain_scores_gemma":[0.9877809,0.01068121,0.0006447196,0.0006245381,0.0001526781,0.0001160089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8969944,0.02029622,0.001422277,0.00003301979,0.001956231,0.00008077804,0.001936937,0.00007771693,0.00005224758,0.0001678967,0.0001315851,0.07685071],"study_design_scores_gemma":[0.8966319,0.06224935,0.0003022007,0.00004427366,0.001525002,0.00001971003,0.0007904585,0.02550831,0.00001679454,0.00007764187,0.01251857,0.000315795],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775727,0.002998878,0.0008871589,0.001020629,0.0008613311,0.01624697,0.0000411491,0.00009798694,0.0002732291],"genre_scores_gemma":[0.9920751,0.00162614,0.0002134394,0.001122753,0.0002846225,0.003830843,0.00003857293,0.00006104608,0.0007474957],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07653492,"threshold_uncertainty_score":0.9999483,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2988078111","doi":"10.1016/j.clinthera.2019.10.002","title":"Perioperative Opioid-sparing Strategies: Utility of Conventional NSAIDs in Adults","year":2019,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Waterloo","funders":"Allergan; Pfizer; Servier; GlaxoSmithKline; AstraZeneca; Johnson and Johnson","keywords":"Medicine; Perioperative; Opioid; Anesthesia; Intensive care medicine; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2747210536853288,"gpt":0.478285728862116,"spread":0.2035646751767872,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001498441,0.0003315421,0.002485842,0.0001125179,0.00002200262,0.00001783149,0.0002438164,0.000512666,0.0003441786],"category_scores_gemma":[0.00006752353,0.0002463807,0.0008864339,0.0002351065,0.0002788263,0.00004541552,0.00005993958,0.0008035019,0.00007814373],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000458186,"about_ca_system_score_gemma":0.0007476487,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001301089,"about_ca_topic_score_gemma":0.000005486767,"domain_scores_codex":[0.9967372,0.0005730714,0.001684427,0.0004772019,0.0002905102,0.0002375549],"domain_scores_gemma":[0.9977882,0.0009866315,0.0004525368,0.0005775641,0.0001125796,0.00008251311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002472394,0.0008356756,0.01175324,0.04157548,0.0008680823,0.00003505115,0.0001969664,0.000001171528,4.019907e-8,0.005802781,0.00009409316,0.9385902],"study_design_scores_gemma":[0.001193868,0.0004679345,0.004209669,0.01753226,0.001056688,0.000008013834,0.0002712843,0.0002830851,9.200898e-8,0.0001058577,0.9746622,0.0002090072],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003283682,0.9918038,0.0002701904,0.0000482093,0.0002066172,0.001589307,0.000007594954,0.00002162829,0.005724234],"genre_scores_gemma":[0.001582755,0.9958241,0.0004274116,0.0006843017,0.0001703491,0.00003816789,0.0001072531,0.00003761393,0.001128052],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9745681,"threshold_uncertainty_score":0.9999989,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1978827950","doi":"10.1016/j.clinthera.2011.11.025","title":"Prescription Drug Use in Pregnancy: A Retrospective, Population-Based Study in British Columbia, Canada (2001–2006)","year":2011,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; Ministry of Health, British Columbia; Michael Smith Health Research BC","keywords":"Medicine; Medical prescription; Pregnancy; Population; Retrospective cohort study; Prescription drug; Family medicine; Obstetrics; Pediatrics; Environmental health; Internal medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.1158794698523038,"gpt":0.3510047166709081,"spread":0.2351252468186043,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006952496,0.0001162923,0.0004540817,0.00005896679,0.00004647235,0.00003964838,0.0001348435,0.0001543857,0.0001326477],"category_scores_gemma":[0.0008202645,0.000160225,0.00007395776,0.0003823961,0.00005741941,0.0001362091,0.00002091845,0.0005657792,0.000004857042],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004138596,"about_ca_system_score_gemma":0.0009615564,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9103894,"about_ca_topic_score_gemma":0.9953426,"domain_scores_codex":[0.9976366,0.0003325532,0.0009102506,0.0004041723,0.0003649254,0.0003515055],"domain_scores_gemma":[0.9987673,0.0002508152,0.0001853164,0.0004732015,0.0001127412,0.0002106943],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000086052,0.002066741,0.989945,0.00002225566,0.00004037555,0.0001349531,0.0002019416,0.000002029242,0.000002571236,0.000002821866,0.0003548982,0.007140368],"study_design_scores_gemma":[0.004415588,0.0003619073,0.9930975,0.0009230227,0.00007189488,0.00000330277,0.000163359,0.0003511696,0.000003322851,0.0001644185,0.0002892488,0.0001552187],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972172,0.0003887456,0.00003917309,0.0001443842,0.0005458763,0.001341188,0.00003504786,0.00004569136,0.0002426661],"genre_scores_gemma":[0.9960844,0.0001543228,0.000342886,0.001734418,0.00005160823,0.00007447083,0.00003547356,0.00002735784,0.001495053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0849532,"threshold_uncertainty_score":0.6533785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089418176","doi":"10.1016/j.clinthera.2007.02.006","title":"Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review","year":2007,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Menopause; Hot flash; Randomized controlled trial; Internal medicine; Gabapentin; Oncology; Clinical trial; Cancer; Gynecology; Intensive care medicine; Alternative medicine; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.58391020650909,"gpt":0.5827162318161314,"spread":0.001193974692958566,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004199781,0.0005313387,0.002753637,0.0001378142,0.0000982967,0.00002003144,0.0004575987,0.0004119501,0.0001425657],"category_scores_gemma":[0.00004238059,0.0002849154,0.0003773347,0.0006405418,0.0002446123,0.00007042804,0.00004292588,0.0006463986,0.0000130123],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000238097,"about_ca_system_score_gemma":0.0008345809,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001096573,"about_ca_topic_score_gemma":0.00008242879,"domain_scores_codex":[0.9953286,0.0006112641,0.002463712,0.0005797018,0.0004521538,0.0005645764],"domain_scores_gemma":[0.9933491,0.003905128,0.0009157378,0.001316597,0.0002324802,0.0002809461],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003118735,0.0008502135,0.0002108391,0.09743903,0.001643827,0.00001174742,0.000007832656,0.000001144493,8.289283e-8,0.0001558191,0.0000578277,0.8993098],"study_design_scores_gemma":[0.001609401,0.001465918,0.001518892,0.2086493,0.01448808,0.00001405792,0.00001100539,0.00004815549,1.549133e-7,0.00003673311,0.7719277,0.000230603],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001366178,0.989405,0.0002281682,0.002477529,0.0005395636,0.007069447,0.0001890769,0.00003077212,0.00004678417],"genre_scores_gemma":[0.00005662894,0.9901013,0.0008768716,0.007429922,0.0003069702,0.0008398685,0.00008417651,0.00009974824,0.0002045549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8990791,"threshold_uncertainty_score":0.9999603,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2005819950","doi":"10.1016/j.clinthera.2005.03.006","title":"The CONCEPT trial: A 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval; Vancouver General Hospital","funders":"","keywords":"Medicine; Formoterol; Salmeterol; Regimen; Dosing; Budesonide/formoterol; Fluticasone propionate; Budesonide; Randomized controlled trial; Double blind; Fluticasone; Pharmacology; Internal medicine; Corticosteroid; Asthma; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.08122762669967477,"gpt":0.3774367020759708,"spread":0.296209075376296,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001966691,0.0003836819,0.001970223,0.0001311449,0.0001211954,0.00003594284,0.0003540755,0.0002350016,0.00001460392],"category_scores_gemma":[0.0001029353,0.0002114141,0.0004518529,0.000373634,0.00160523,0.0002435816,0.00008077101,0.0005490846,0.000001205323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001068565,"about_ca_system_score_gemma":0.0003947642,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000088997,"about_ca_topic_score_gemma":0.0001323327,"domain_scores_codex":[0.9953622,0.0005743096,0.002163691,0.0005386772,0.0007591081,0.0006020511],"domain_scores_gemma":[0.9958149,0.0009555919,0.001497476,0.000850977,0.000621185,0.0002598837],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9692908,0.003215483,0.008466094,0.0002384605,0.0006815261,0.000008461849,0.001858836,0.0006653684,0.0002035395,0.0001836403,0.00001935799,0.01516844],"study_design_scores_gemma":[0.9548504,0.01079936,0.0006334772,0.003002763,0.0009740106,0.0000116324,0.006352674,0.01692914,0.004132816,0.00001324116,0.001984565,0.0003158742],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901538,0.003735011,0.0008626398,0.0006230111,0.0001052147,0.004241205,0.00001538499,0.00003632878,0.0002273475],"genre_scores_gemma":[0.9931086,0.000521171,0.005623221,0.0002347771,0.0001263103,0.00009349347,0.00001667021,0.00006728719,0.0002084994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01626377,"threshold_uncertainty_score":0.8621217,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149756516","doi":"10.1016/j.clinthera.2006.12.012","title":"A meta-analysis of broad-spectrum antibiotic therapy in patients with active Crohn's disease","year":2006,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":96,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Crohn's disease; Internal medicine; Meta-analysis; Placebo; Clinical trial; Randomized controlled trial; Antibiotics; Antimicrobial; Metronidazole; MEDLINE; Odds ratio; Disease; Pathology; Alternative medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1220163923126354,"gpt":0.3898936299144202,"spread":0.2678772376017848,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004182825,0.0006068965,0.003193793,0.0002615789,0.0000357182,0.00002404075,0.0005245958,0.000531079,0.00005184344],"category_scores_gemma":[0.00003998086,0.0004068404,0.004084358,0.0006070095,0.0003407912,0.00000507546,0.0001047177,0.0003746816,0.000006105427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003260928,"about_ca_system_score_gemma":0.0004562378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005734209,"about_ca_topic_score_gemma":0.00003695545,"domain_scores_codex":[0.9961315,0.0008738138,0.001427485,0.0008594717,0.0003413114,0.0003664408],"domain_scores_gemma":[0.9971988,0.0001562944,0.0009895554,0.001316604,0.0001578503,0.0001808583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003479299,0.004900068,0.0404312,0.001808235,0.5954733,0.0002188559,0.00001644135,0.0001426761,4.658391e-7,0.00006051299,0.00006682797,0.3534021],"study_design_scores_gemma":[0.001597186,0.0004865923,0.3762616,0.0001631181,0.4347245,2.037774e-7,0.000002261272,0.00001443723,0.000002979719,0.00002823544,0.1858972,0.0008217411],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02528175,0.9722478,0.0000354552,0.00001211213,0.00008798373,0.001336482,0.000892497,0.0000127149,0.00009319079],"genre_scores_gemma":[0.01224508,0.9853525,0.00006920051,0.0002865308,0.0001045799,0.00004397765,0.001623952,0.0001050719,0.0001691724],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3525804,"threshold_uncertainty_score":0.9998384,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2017030986","doi":"10.1016/j.clinthera.2005.05.005","title":"Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study","year":2005,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Eli Lilly (Canada); Dartmouth General Hospital","funders":"","keywords":"Medicine; Pioglitazone; Insulin; Glycemic; Internal medicine; Type 2 diabetes; Placebo; Diabetes mellitus; Type 2 Diabetes Mellitus; Clinical endpoint; Glycated hemoglobin; Endocrinology; Randomized controlled trial; Gastroenterology","retraction":null,"screen_n_in":null,"score":{"opus":0.03159977064551277,"gpt":0.3155616811049198,"spread":0.2839619104594071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001395305,0.0004717908,0.002479984,0.0003353369,0.00003207238,0.00002390079,0.0001927926,0.0001285867,0.000005463581],"category_scores_gemma":[0.0002024241,0.0002700471,0.0002028626,0.0007201716,0.000371566,0.0001834865,0.00005050896,0.0003441641,0.000003830005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000759968,"about_ca_system_score_gemma":0.000112973,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004695434,"about_ca_topic_score_gemma":0.0001198125,"domain_scores_codex":[0.9958626,0.0006743346,0.001668012,0.0006372195,0.0007445276,0.0004133278],"domain_scores_gemma":[0.996411,0.001455438,0.000844115,0.0006422646,0.0004682942,0.0001789387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5908772,0.03371045,0.3571443,0.00008611034,0.002581371,0.00001086967,0.0008988368,0.00008522467,0.000005092099,0.00007759329,0.000001354067,0.01452154],"study_design_scores_gemma":[0.6138803,0.01268366,0.3702665,0.0003369823,0.001413789,2.298104e-8,0.00006970924,0.0008386082,0.0002122131,0.00002422744,0.00008251893,0.0001915219],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9789229,0.00429727,0.00002736081,0.0004172557,0.00007373216,0.01613726,0.00001419534,0.0000361212,0.00007387835],"genre_scores_gemma":[0.9951065,0.002342755,0.0008710103,0.000657501,0.00003579542,0.0007828396,0.00007921912,0.00006107098,0.00006337768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02300303,"threshold_uncertainty_score":0.9999751,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2054421884","doi":"10.1016/j.clinthera.2014.09.017","title":"Hypnotics in Insomnia: The Experience of Zolpidem","year":2014,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Sleep and related disorders","field":"Psychology","cited_by":94,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal; Université Laval; Institut Universitaire en Santé Mentale de Québec; Canadian Sleep & Circadian Network; University of Toronto","funders":"Servier; Canada Research Chairs; Valeant Pharmaceuticals International","keywords":"Zolpidem; Insomnia; Medicine; Bedtime; Anxiety; Primary Insomnia; Hypnotic; Psychiatry; Population; Sleep disorder","retraction":null,"screen_n_in":null,"score":{"opus":0.2548751536100162,"gpt":0.5199757908516316,"spread":0.2651006372416154,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00141943,0.0003599563,0.001980753,0.0001029823,0.00004449639,0.00001200068,0.001026576,0.001432107,0.0002011107],"category_scores_gemma":[0.0002210361,0.0002039402,0.0008821087,0.0005111834,0.0008106853,0.00001591693,0.0001072757,0.001683935,0.0002988507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002153617,"about_ca_system_score_gemma":0.0001021779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001596797,"about_ca_topic_score_gemma":0.000008480618,"domain_scores_codex":[0.995239,0.001492821,0.002226885,0.0004733024,0.0001940782,0.0003738785],"domain_scores_gemma":[0.9930794,0.004808783,0.0008065053,0.001189989,0.00004565603,0.00006964982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000134494,0.0005617897,0.0002129402,0.0003564715,0.000676613,0.00000511841,0.0008210072,0.000001124606,6.763182e-9,0.002420289,0.0002283477,0.9947028],"study_design_scores_gemma":[0.0006910146,0.0001299342,0.00005581755,0.001282502,0.0009707256,0.000006997187,0.0003613622,0.0000173186,3.20011e-8,0.000422749,0.9958274,0.0002341165],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001164637,0.9882345,0.0001261212,0.00009079509,0.002972072,0.0005816898,0.000006294966,0.00002908574,0.007842979],"genre_scores_gemma":[0.0002838564,0.997737,0.00006009507,0.001048401,0.0002564076,0.00005759445,0.000008195964,0.00006303206,0.0004854161],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9955991,"threshold_uncertainty_score":0.9998642,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031244515","doi":"10.1016/j.clinthera.2006.11.017","title":"Cost-effectiveness of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia: A Canadian perspective","year":2006,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Pfizer (Canada); University of Toronto; Mount Sinai Hospital; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Pregabalin; Medicine; Postherpetic neuralgia; Gabapentin; Neuropathic pain; Peripheral neuropathy; Brief Pain Inventory; Neuralgia; Anesthesia; Chronic pain; Diabetes mellitus; Internal medicine; Physical therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.06844249996525661,"gpt":0.3515527024553134,"spread":0.2831102024900568,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002820716,0.0001784787,0.0004323076,0.00004342069,0.00008578708,0.00001114381,0.00009982002,0.00009446686,0.000004751645],"category_scores_gemma":[0.0001678231,0.0001112874,0.0001402109,0.0001735716,0.0002720401,0.00001949831,0.00001993936,0.0001806585,2.785266e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009004715,"about_ca_system_score_gemma":0.0001072152,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001075889,"about_ca_topic_score_gemma":0.0006288529,"domain_scores_codex":[0.9977204,0.001199722,0.0003611511,0.0002831247,0.0001745156,0.0002610547],"domain_scores_gemma":[0.99649,0.002709667,0.0001746582,0.0002819624,0.0002432922,0.0001003904],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007730411,0.007177127,0.7705984,0.001772497,0.008792195,0.0007319207,0.001317356,0.0005775824,0.003616208,0.03560086,0.00002829997,0.1620572],"study_design_scores_gemma":[0.006306317,0.005157128,0.9665233,0.0006600891,0.002147289,0.00001469225,0.0005645659,0.01470086,0.0004515862,0.003111019,0.0001626613,0.0002004999],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988375,0.001239357,0.006127935,0.0007609559,0.0001156661,0.003071784,0.00005886276,0.00002527955,0.0002251692],"genre_scores_gemma":[0.9986982,0.0001689129,0.0003717266,0.000522915,0.00002543279,0.0001002111,0.00001258072,0.00003872514,0.00006129354],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.195925,"threshold_uncertainty_score":0.4538168,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2001067466","doi":"10.1016/j.clinthera.2008.12.023","title":"Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: Results of the CAP (Comparative Atorvastatin Pleiotropic effects) study","year":2008,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Clinical Research Institute; University of Ottawa","funders":"Pfizer Canada","keywords":"Atorvastatin; Medicine; C-reactive protein; Coronary artery disease; Internal medicine; Triglyceride; National Cholesterol Education Program; Gastroenterology; Statin; Clinical endpoint; Lipoprotein; Cholesterol; Endocrinology; Inflammation; Cardiology; Randomized controlled trial; Metabolic syndrome; Obesity","retraction":null,"screen_n_in":null,"score":{"opus":0.06857215870727022,"gpt":0.3439261744786169,"spread":0.2753540157713467,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009132398,0.0004157252,0.001753683,0.0000904592,0.0001343582,0.000007145896,0.0001662804,0.0001393757,0.000005687279],"category_scores_gemma":[0.0004224844,0.0002651817,0.0003368873,0.0004656905,0.0006281428,0.00009066623,0.00009068543,0.0007422713,0.000009205266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001898657,"about_ca_system_score_gemma":0.0005450257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000190495,"about_ca_topic_score_gemma":0.0001224426,"domain_scores_codex":[0.99385,0.002837446,0.00107764,0.0006523393,0.001167713,0.0004148608],"domain_scores_gemma":[0.9943813,0.002956651,0.0008461712,0.001127626,0.0004475599,0.0002406648],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1545165,0.02876195,0.7959924,0.0009460343,0.005678362,0.0004886724,0.00779801,0.0003205157,0.0009168501,0.0001129754,0.0001637456,0.004303965],"study_design_scores_gemma":[0.03598995,0.01430937,0.9432295,0.0006416288,0.0004811911,0.00000158022,0.0003691721,0.0001377943,0.004508748,0.0000197468,0.00007318687,0.0002381563],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923646,0.0001556769,0.00005169962,0.00006533994,0.0003064593,0.006833911,0.0001230924,0.00002739191,0.00007180964],"genre_scores_gemma":[0.9992024,0.00001471766,0.0002547855,0.0001253004,0.0001056801,0.0001473649,0.00004699858,0.00003812962,0.00006457265],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.147237,"threshold_uncertainty_score":0.99998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2075000534","doi":"10.1016/j.clinthera.2013.08.007","title":"Epidermal Growth Factor Receptor: Pathway, Therapies, and Pipeline","year":2013,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Medicine; KRAS; Epidermal growth factor receptor; EGFR inhibitors; T790M; Cetuximab; Colorectal cancer; Erlotinib; Oncology; Lung cancer; Panitumumab; Cancer; Cancer research; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.2177731275188743,"gpt":0.4774846052985893,"spread":0.259711477779715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002495928,0.0005128416,0.002220909,0.00008364414,0.00009280314,0.00005305238,0.0001513976,0.0006596077,0.0005053247],"category_scores_gemma":[0.0001022027,0.0003153881,0.0007060639,0.0001579505,0.0002421268,0.00006153077,0.00006874844,0.0007619894,0.0002797245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001065048,"about_ca_system_score_gemma":0.0005767542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001393648,"about_ca_topic_score_gemma":0.000001439549,"domain_scores_codex":[0.997323,0.0002896007,0.00126339,0.0005657397,0.0002212898,0.0003370172],"domain_scores_gemma":[0.9974988,0.001060336,0.0004295096,0.0005319536,0.000170643,0.0003087886],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001179434,0.0002903646,0.000235239,0.002000235,0.001434389,0.000008663102,0.00006577908,2.878419e-9,3.622341e-7,0.0001768603,0.002054774,0.9937215],"study_design_scores_gemma":[0.001033374,0.0003971887,0.00008402427,0.002332266,0.002941733,0.00003831515,0.00001723009,0.000005251371,8.939384e-7,0.0001460963,0.9927034,0.0003001688],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003746779,0.9954804,0.0001014792,0.000759176,0.0007820016,0.00152912,0.0002056826,0.0001009027,0.00100373],"genre_scores_gemma":[0.00002682348,0.99015,0.001784881,0.001813036,0.001060515,0.0001367604,0.0003377603,0.000115898,0.004574293],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9934214,"threshold_uncertainty_score":0.9999298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031543029","doi":"10.1016/j.clinthera.2009.06.004","title":"Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder","year":2009,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":89,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Public Health; University of Toronto","funders":"H. Lundbeck A/S","keywords":"Medicine; Escitalopram; Generalized anxiety disorder; Anxiety; MEDLINE; Quality of life (healthcare); Psychiatry; Checklist; Population; Economic evaluation; Health care; Clinical psychology; Psychology; Environmental health; Nursing","retraction":null,"screen_n_in":null,"score":{"opus":0.5233248457434514,"gpt":0.6402287132785927,"spread":0.1169038675351413,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00876184,0.0006860017,0.007967819,0.0002795118,0.000112218,0.00002649588,0.000422579,0.0006104268,0.0001180055],"category_scores_gemma":[0.003591141,0.0004970223,0.0008373794,0.0006991541,0.0004586492,0.00006881747,0.000194108,0.0005572045,0.00002835262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001120758,"about_ca_system_score_gemma":0.000324922,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001786084,"about_ca_topic_score_gemma":0.0000109339,"domain_scores_codex":[0.9848446,0.007035319,0.006343309,0.001080616,0.0003720723,0.0003241246],"domain_scores_gemma":[0.9857858,0.00799556,0.004150661,0.001221183,0.0006122056,0.0002346334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002879233,0.0008773541,0.005498935,0.4301746,0.009514772,2.249544e-7,0.0002834486,5.150058e-7,7.671854e-8,0.003904171,0.000190273,0.5495269],"study_design_scores_gemma":[0.007282548,0.001978463,0.0203504,0.4038002,0.07784561,0.00001907848,0.001355046,0.00001488342,2.385965e-7,0.006419693,0.4781344,0.002799394],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004295071,0.9930503,0.0002802516,0.0002365736,0.0006964235,0.004552147,0.0002444431,0.00004296139,0.0004674047],"genre_scores_gemma":[0.0003316137,0.9962753,0.001073085,0.001066315,0.00006882325,0.000564853,0.00007845393,0.00006866132,0.0004729147],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5467275,"threshold_uncertainty_score":0.9997482,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2033163507","doi":"10.1016/j.clinthera.2013.12.011","title":"Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Pfizer","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Atrial fibrillation; Stroke (engine); Discontinuation; Cost effectiveness; Randomized controlled trial; Quality-adjusted life year; Warfarin; Quality of life (healthcare); Internal medicine; Intensive care medicine; Cardiology; Anesthesia","retraction":null,"screen_n_in":null,"score":{"opus":0.4687215229406663,"gpt":0.5252876808651197,"spread":0.05656615792445335,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001521246,0.0001104915,0.0005387314,0.00008014901,0.00002142816,0.00001029421,0.00005580076,0.0001603793,0.00002847648],"category_scores_gemma":[0.0005033155,0.00009519599,0.0004043528,0.0001226132,0.00004930768,0.00005728878,0.00002104786,0.00008032144,0.000009682895],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002966649,"about_ca_system_score_gemma":0.00005906333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001028215,"about_ca_topic_score_gemma":0.0000128645,"domain_scores_codex":[0.9985943,0.0003009428,0.000589296,0.0001976971,0.0001666258,0.0001511455],"domain_scores_gemma":[0.9973349,0.002135369,0.0002068779,0.0001969417,0.00006686379,0.00005905502],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01366263,0.0000215581,0.7327172,0.0001047616,0.0003779319,1.745143e-7,0.00002893284,0.0004776395,0.0004326343,0.002137512,0.0000276703,0.2500114],"study_design_scores_gemma":[0.05589091,0.00304358,0.8090014,0.0002430618,0.001090231,5.27453e-7,0.00004100072,0.02190297,0.001319592,0.004054902,0.1031209,0.0002908074],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9466023,0.0001387583,0.04868535,0.0004378431,0.001512722,0.002163872,0.000009021941,0.00004166361,0.0004084569],"genre_scores_gemma":[0.9946026,0.00008708311,0.002675523,0.00006994997,0.001847962,0.000001402534,0.00003832199,0.00002329025,0.0006538236],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2497206,"threshold_uncertainty_score":0.388198,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130331850","doi":"10.1016/j.clinthera.2015.05.495","title":"Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing","year":2015,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Children's & Women's Health Centre of British Columbia","funders":"World Health Organization","keywords":"Medicine; Dosing; Pharmacokinetics; Warfarin; Pharmacodynamics; Overweight; Population; Vancomycin; Therapeutic drug monitoring; Obesity; Intensive care medicine; Pediatrics; Pharmacology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5346818210259923,"gpt":0.5971420242447313,"spread":0.06246020321873902,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001487583,0.0003634553,0.001872796,0.00006550576,0.0001620383,0.00005151301,0.0001825673,0.000337135,0.00001466416],"category_scores_gemma":[0.0003301286,0.0002617452,0.0005525932,0.0002675409,0.0001742346,0.00004572862,0.0001633066,0.0008795841,0.00002318509],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005702059,"about_ca_system_score_gemma":0.0003140238,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":7.345351e-7,"about_ca_topic_score_gemma":3.075736e-7,"domain_scores_codex":[0.9976843,0.0002331527,0.001081376,0.0004922053,0.0001593729,0.0003495796],"domain_scores_gemma":[0.9943417,0.004146924,0.0004875763,0.0003649841,0.0002500082,0.0004087693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003745689,0.0002886391,0.0006981852,0.005639354,0.0005721636,0.000001920419,0.00001521731,2.521213e-8,7.044959e-8,0.0001359039,0.003977276,0.9886338],"study_design_scores_gemma":[0.001047916,0.0001774229,0.0001140557,0.0004576221,0.01898604,0.00003617521,0.000006910945,0.00003257964,1.125786e-7,0.000531701,0.9783417,0.0002677476],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002903492,0.9944685,0.000193254,0.002176257,0.0006190868,0.001619513,0.0001211326,0.00006522866,0.0007080378],"genre_scores_gemma":[0.00001620455,0.9927285,0.001618725,0.002506093,0.002573313,0.000100701,0.00006605159,0.00007190149,0.0003185643],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9883661,"threshold_uncertainty_score":0.9999835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2086969647","doi":"10.1016/s0149-2918(03)80282-5","title":"Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension","year":2003,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Eplerenone; Medicine; Aldosterone; Spironolactone; Essential hypertension; Internal medicine; Pharmacology; Cardiology; Blood pressure","retraction":null,"screen_n_in":null,"score":{"opus":0.04266148168984978,"gpt":0.3192951560136691,"spread":0.2766336743238194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002426376,0.0001152281,0.0003762762,0.00003508679,0.00004679088,0.000004655501,0.00004442855,0.0001317016,0.00002493859],"category_scores_gemma":[0.0001289255,0.00006371245,0.00006897886,0.0001794504,0.0002241224,0.00002447527,0.00002787471,0.0002514964,0.000002862439],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002023838,"about_ca_system_score_gemma":0.00007221605,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001701534,"about_ca_topic_score_gemma":0.000007745919,"domain_scores_codex":[0.9987997,0.0001619802,0.0004394104,0.0002082866,0.000251737,0.0001388727],"domain_scores_gemma":[0.9990947,0.0002638386,0.0001218117,0.0002486891,0.0001974259,0.00007354738],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00256817,0.001036862,0.9754778,0.000009916726,0.0001104566,0.000004867382,0.0000632993,0.000002990695,0.0005160347,0.00007863838,0.000009555159,0.02012147],"study_design_scores_gemma":[0.009842011,0.0006894022,0.9878419,0.0001061654,0.0001798624,0.00001322872,0.000007511243,0.0001196825,0.0005407077,0.00001940771,0.0005623939,0.00007774991],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985321,0.0001914127,0.00007720244,0.0005338867,0.00009287367,0.0004125671,0.000001699718,0.000007398553,0.0001509126],"genre_scores_gemma":[0.9984878,0.0001492573,0.0002422859,0.0009405316,0.0000278373,9.129927e-7,0.000005509023,0.00001679773,0.0001290578],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02004372,"threshold_uncertainty_score":0.2598118,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3089860191","doi":"10.1016/j.clinthera.2020.09.012","title":"Caregivers' Willingness to Accept Expedited Vaccine Research During the COVID-19 Pandemic: A Cross-sectional Survey","year":2020,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women and Children’s Health Research Institute; Alberta Children's Hospital; University of Calgary; University of Alberta; University of Saskatchewan; BC Children's Hospital; University of Toronto; SickKids Foundation; Hospital for Sick Children; University of British Columbia","funders":"","keywords":"Medicine; Pandemic; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cross-sectional study; Virology; Family medicine; Internal medicine; Infectious disease (medical specialty); Outbreak; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.5822064516313651,"gpt":0.5673103875499281,"spread":0.01489606408143695,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007058248,0.0001534748,0.0002919366,0.00005018655,0.001811297,0.0003079827,0.001056226,0.0002992003,0.0007757699],"category_scores_gemma":[0.007427699,0.0001185115,0.0001825592,0.001135779,0.0001500789,0.000164865,0.0002645082,0.0009128113,0.0001547319],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002260214,"about_ca_system_score_gemma":0.0006788324,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000661327,"about_ca_topic_score_gemma":0.002228752,"domain_scores_codex":[0.9950952,0.002262302,0.0006333796,0.0005699429,0.0008432341,0.0005959465],"domain_scores_gemma":[0.9918776,0.006256289,0.0001179562,0.0003796391,0.000644877,0.0007236966],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000501632,0.00005538193,0.9870713,0.00001051966,0.00005420636,0.000009883574,0.008946061,0.0000798142,0.00002818106,0.0002050579,0.002384797,0.0006531174],"study_design_scores_gemma":[0.0008073316,0.0001221479,0.7737091,0.000003000799,0.000007419908,0.000001162321,0.001468284,0.00003644024,0.000004365304,0.0002826325,0.2234161,0.0001420347],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9811245,0.0003205547,0.0007117739,0.01575834,0.0007918191,0.0005310188,0.00003910095,0.0001528156,0.000570147],"genre_scores_gemma":[0.9812478,0.0008693424,0.00003542036,0.01344011,0.00323976,0.00002279798,0.00001046566,0.00002488335,0.001109375],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2210313,"threshold_uncertainty_score":0.9994882,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985652007","doi":"10.1016/j.clinthera.2006.11.002","title":"Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database study","year":2006,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University; Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Medical prescription; Risperidone; Quetiapine; Antipsychotic; Retrospective cohort study; Cohort; Psychiatry; Olanzapine; Proportional hazards model; Schizophrenia (object-oriented programming); Pediatrics; Database; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.1119424600961543,"gpt":0.3936045367776961,"spread":0.2816620766815418,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004638819,0.0001674243,0.0003503616,0.00006066044,0.0001358782,0.00005868909,0.00004872688,0.0000775429,8.542194e-7],"category_scores_gemma":[0.00009809745,0.00009557265,0.0000205219,0.000201046,0.00008973524,0.0001109896,0.00002114279,0.0002285181,1.720672e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001197066,"about_ca_system_score_gemma":0.0001109763,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005140722,"about_ca_topic_score_gemma":0.03630281,"domain_scores_codex":[0.9986431,0.0001116828,0.0003154713,0.0004157521,0.0002631611,0.0002508116],"domain_scores_gemma":[0.9988038,0.000506555,0.0001478375,0.0001899549,0.000267768,0.00008410494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02747726,0.001357092,0.9696309,0.00003138539,0.0002024189,0.000004256819,0.0002056388,0.00000938523,0.000001315695,0.0001912686,0.0000132387,0.0008758227],"study_design_scores_gemma":[0.03024558,0.00442899,0.9624223,0.0001951178,0.0002586757,0.000001223522,0.0002728892,0.001769218,0.000004639445,0.0002640754,0.00001985389,0.0001174052],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943488,0.0003426256,0.001016437,0.0006815332,0.00001830929,0.003492003,0.00008378575,0.00001365643,0.000002907204],"genre_scores_gemma":[0.9959947,0.00008132651,0.003353187,0.000129992,0.0000429618,0.0002050449,0.00008564943,0.00002547028,0.00008160523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03578874,"threshold_uncertainty_score":0.9812822,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2006000651","doi":"10.1016/s0149-2918(02)80063-7","title":"Development of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adults","year":2002,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Drug; Intensive care medicine; Family medicine; Pharmacology","retraction":null,"screen_n_in":null,"score":{"opus":0.2682794857251483,"gpt":0.4752922326927924,"spread":0.207012746967644,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002258389,0.0001808263,0.001068859,0.0001256223,0.00002162022,0.000002427796,0.0001897114,0.0003056192,0.0004139105],"category_scores_gemma":[0.0008031284,0.0001460757,0.0003297382,0.0004343038,0.0005602508,0.00003917799,0.00009339655,0.0007413769,0.00001087577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002628231,"about_ca_system_score_gemma":0.0001612741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001556873,"about_ca_topic_score_gemma":0.00001310945,"domain_scores_codex":[0.9952339,0.0004646466,0.003332676,0.0003212073,0.0003914673,0.000256121],"domain_scores_gemma":[0.9954765,0.002597911,0.001175196,0.0004104959,0.0001414494,0.0001983974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001186999,0.007486198,0.920033,0.0004159434,0.0004963306,0.000007252543,0.00124759,0.000001891823,0.0001600864,0.00007384465,0.0001769076,0.06871393],"study_design_scores_gemma":[0.02185399,0.00108425,0.9329118,0.001270543,0.0007482197,0.000006952061,0.0007082214,0.008680826,0.007362192,0.0001308489,0.02486123,0.0003809489],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959003,0.0007835894,0.00001781047,0.0005537858,0.0003443402,0.0007264715,0.00001290025,0.00001652946,0.001644223],"genre_scores_gemma":[0.994072,0.0009258332,0.004050636,0.000566705,0.00003296841,0.000006227704,0.000009604355,0.00002142817,0.0003145909],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06833299,"threshold_uncertainty_score":0.5956794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3018455288","doi":"10.1016/j.clinthera.2020.03.006","title":"Use of Real-world Data for New Drug Applications and Line Extensions","year":2020,"lang":"en","type":"review","venue":"Clinical Therapeutics","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":78,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Sanofi","keywords":"Medicine; Orphan drug; Timeline; Drug; Agency (philosophy); Regulatory science; Food and drug administration; Drug approval; Tolerability; Regulatory agency; MEDLINE; Pharmacology; Family medicine; Data science; Adverse effect; Bioinformatics; Computer science; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.7882468021714223,"gpt":0.643252198100617,"spread":0.1449946040708053,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008755557,0.0004559788,0.002080544,0.000133789,0.0002029792,0.00002944964,0.0008721782,0.0004448027,0.00006455365],"category_scores_gemma":[0.0002221551,0.0003910122,0.0005410395,0.0005368155,0.0005457042,0.0001592543,0.0004555767,0.001732236,0.00005686081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000339501,"about_ca_system_score_gemma":0.0007527355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000186172,"about_ca_topic_score_gemma":0.00003974829,"domain_scores_codex":[0.9965003,0.000544426,0.001610334,0.0008520415,0.0001253643,0.0003675141],"domain_scores_gemma":[0.9881037,0.009181015,0.0009836343,0.001081748,0.000130422,0.0005194418],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007962861,0.0003467581,0.00004451326,0.001365889,0.001196925,0.000004190036,0.00001829588,0.000005871252,0.000006357128,0.000983712,0.02160622,0.9743416],"study_design_scores_gemma":[0.0006350165,0.00006244535,0.000007104792,0.0004107394,0.00720804,0.000007067938,0.000009765002,0.001348384,0.000006997433,0.0002806874,0.989674,0.0003497664],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000007530057,0.9879832,0.001211887,0.001484593,0.000987835,0.002618038,0.005360155,0.0001246973,0.000222026],"genre_scores_gemma":[0.00001226659,0.9880803,0.002761752,0.003054762,0.001822317,0.0001543702,0.001461648,0.00008760822,0.002565017],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9739919,"threshold_uncertainty_score":0.9998542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}